StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead (GILD) to Sell $7.25B of Bonds to Fund Immunomedics (IMMU) Deal - Bloomberg
September 23, 2020 2:03 PM
Gilead (NASDAQ:
GILD
) to Sell $7.25B of Bonds to Fund Immunomedics (NASDAQ:
IMMU
) Deal - Bloomberg
Categories
Corporate News
Next Articles
Gilead Sciences (GILD), Galapagos NV (GLPG) Announce European Commission Grants Marketing Authorization for Jyseleca (Filgotinib) for Treatment of Adults with Moderate to Severe Active RA
September 25, 2020 1:16 PM
Gilead Sciences (GILD), Galapagos NV (GLPG) Report Jyseleca (filgotinib) Approved in Japan for Rheumatoid Arthritis
September 25, 2020 6:31 AM
